Lyka Labs Share Price
Small Cap | Pharmaceuticals and health care | NSE: LYKALABS | BSE: 500259
₹99.35 
-1.05 (-1.05 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 104.00
High (₹) 104.00
Low (₹) 98.10
Prev. Close (₹) 100.40
Volume 48,164
VWAP (₹) 106.31
ROCE (%) 3.66
Industry P/E 43.95
TTM P/E 85.65
P/B Ratio 4.82
Market Cap (₹) Cr.354.51
Dividend Yield (%)--
EPS (₹) -0.79
ROE-3.83%
Sales Growth (%) 19.47
Profit Growth (%)-80.08
Day Range
104.00104.00
52 Week Range
90.20175.95
Historical Returns
Returns (6M)
-36.35 %
Returns (1Y)
-9.64 %
Returns (3Y)
-28.47 %
Returns (5Y)
609.64 %
Returns (6M)
-36.35 %
Returns (1Y)
-9.64 %
Returns (3Y)
-28.47 %
Returns (5Y)
609.64 %
SWOT Analysis
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
Technicals
Technical Rating
BEARISHRSI 27.45
MFI 9.75
ATR 6.67
Commodity Channel Index -115.65
ROC125 -29.26
ROC21 -27.55
Williams %R -96.49
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 108.41 | 112.03 | 114.51 | 105.93 | 102.31 | 99.83 | 96.21 |
| Week Ago | 120.00 | 121.65 | 123.20 | 118.45 | 116.80 | 115.25 | 113.60 |
| Month Ago | 148.00 | 154.45 | 160.95 | 141.50 | 135.05 | 128.55 | 122.10 |
EMA & SMA
99.35
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 114.18
9 Day 113.82
10 Day 115.69
12 Day 119.30
14 Day 120.72
20 Day 127.12
26 Day 132.50
50 Day 143.15
100 Day 145.90
200 Day 135.46
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 02 Dec, 2021 | ₹181.50 | 1,50,007 | BSE |
| MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 02 Dec, 2021 | ₹181.50 | 7 | BSE |
| BISHWANATH PRASAD AGARWAL | bulk | Buy | 01 Dec, 2021 | ₹170.20 | 2,14,000 | BSE |
| SHRUTI MAYANK SHAH | block | Sell | 24 Nov, 2021 | ₹130.40 | 15,00,000 | BSE |
| PRASHAM MAYANK SHAH | block | Sell | 24 Nov, 2021 | ₹130.40 | 15,00,000 | BSE |
| MAYANK JASHWANTLAL SHAH | block | Sell | 24 Nov, 2021 | ₹130.40 | 18,00,000 | BSE |
| IPCA LABORATORIES LIMITED | block | Buy | 24 Nov, 2021 | ₹130.40 | 18,00,000 | BSE |
| SHRUTI MAYANK SHAH | bulk | Sell | 24 Nov, 2021 | ₹130.40 | 15,00,000 | BSE |
| PRASHAM MAYANK SHAH | bulk | Sell | 24 Nov, 2021 | ₹130.40 | 15,00,000 | BSE |
| MAYANK JASHWANTLAL SHAH | bulk | Sell | 24 Nov, 2021 | ₹130.40 | 18,00,000 | BSE |
| IPCA LABORATORIES LIMITED | bulk | Buy | 24 Nov, 2021 | ₹130.40 | 48,00,000 | BSE |
| DADAL&BROACHA STOCK BROKING PVT LTD | block | Sell | 23 Nov, 2021 | ₹128.45 | 7,98,786 | BSE |
| AMEE PARIKH | block | Sell | 23 Nov, 2021 | ₹124.20 | 9,75,356 | BSE |
| IPCA LABORATORIES LIMITED | block | Buy | 23 Nov, 2021 | ₹124.20 | 9,75,356 | BSE |
| DADAL&BROACHA STOCK BROKING PVT LTD | bulk | Sell | 23 Nov, 2021 | ₹128.45 | 7,98,786 | BSE |
| AMEE PARIKH | bulk | Sell | 23 Nov, 2021 | ₹124.20 | 9,75,356 | BSE |
| IPCA LABORATORIES LIMITED | bulk | Buy | 23 Nov, 2021 | ₹126.11 | 17,74,142 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 17 Apr, 2024 | Ipca Laboratories Limited | Acquisition | ₹139.50 | 26,00,000 | BSE |
| 12 Jul, 2023 | Nehal Narendra Gandhi | Revoke | ₹ | 4,600 | BSE |
| 12 Jul, 2023 | Nehal Narendra Gandhi | Revoke | ₹ | 53,000 | BSE |
| 12 Jul, 2023 | Nehal Narendra Gandhi | Revoke | ₹ | 900 | BSE |
| 12 Jul, 2023 | Nehal Narendra Gandhi | Revoke | ₹ | 1,500 | BSE |
| 20 Apr, 2023 | Ipca Laboratories Limited | Acquisition | ₹139.50 | 24,00,000 | BSE |
| 03 Apr, 2023 | Nehal Narendra Gandhi | Acquisition | ₹ | 6,34,429 | BSE |
| 03 Apr, 2023 | Narendra Ishwarlal Gandhi | Disposal | ₹ | 6,34,429 | BSE |
| 31 Mar, 2023 | Narendra Ishwarlal Gandhi | Disposal | ₹ | 1,48,000 | BSE |
| 31 Mar, 2023 | Nehal Narendra Gandhi | Acquisition | ₹ | 1,48,000 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 05 Mar, 2025 | NSE India | Voting results of the meeting of the Preference Shareholders of the Companyconvened on Tuesday, 4th March 2025, as per the NCLT Order |
| 05 Mar, 2025 | NSE India | Voting results of the meeting of the Unsecured Creditors of the Companyconvened as per the NCLT order on Tuesday, 4th March 2025 |
| 05 Mar, 2025 | NSE India | Voting results of the meeting of the Secured Creditors of the Company conveyedas per the NCLT order on Tuesday, 4th March 2025 |
| 05 Mar, 2025 | NSE India | Lyka Labs Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on March 04, 2025 |
| 05 Mar, 2025 | BSE India | As per letter attached |
| 05 Mar, 2025 | BSE India | As per letter attached |
| 05 Mar, 2025 | BSE India | As per letter attached. |
| 05 Mar, 2025 | BSE India | As per letter attached |
| 04 Mar, 2025 | NSE India | Lyka Labs Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on March 04, 2025 along with a copy of minutes. |
| 04 Mar, 2025 | BSE India | Summary of proceedings of the Meeting of Equity Shareholders, Secured Creditors, Unsecured Creditors and Preference Shareholder of Company convened pursuant to Order dated 25th January, 2025 passed by the Hon''ble National Company Law Tribunal Division Bench- Court- I Ahmedabad |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 31 Dec, 2024 | 04 Feb, 2025 |
| Quarterly Results | -- | 23 Oct, 2024 | 12 Nov, 2024 |
| Others | Inter-alia, to consider and approve filling of fresh application of scheme of amalgamation of Lyka Exports Limited (Company’s subsidiary) with the Company. | 07 Oct, 2024 | 11 Oct, 2024 |
| Quarterly Results | -- | 02 Aug, 2024 | 09 Aug, 2024 |
| Audited Results & Others | To consider other business matters | 27 May, 2024 | 21 May, 2024 |
| Others | inter alia: to allot and issue 26,00,000 Equity Shares upon conversion of 26,00,000 Warrants to Ipca Laboratories Limited, part of a Promoter Group. | 11 Apr, 2024 | 16 Apr, 2024 |
| Quarterly Results | -- | 01 Feb, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 23 Oct, 2023 | 02 Nov, 2023 |
| Quarterly Results | -- | 27 Jul, 2023 | 02 Aug, 2023 |
| Audited Results | -- | 17 May, 2023 | 23 May, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Apr, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Lyka Labs
Lyka Labs is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 106.40 Cr. and Equity Capital is Rs. 33.09 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1976
Managing Director
Mr. Kunal Gandhi
NSE Symbol
LYKALABS
Lyka Labs Management
| Name | Designation |
|---|---|
| Mr. Babulal Jain | Chairman |
| Mr. Kunal Gandhi | Managing Director & CEO |
| Mr. Yogesh B Shah | Executive Director & CFO |
| Mr. Shashil Mendosa | Non Executive Director |
| Mr. Prashant Godha | Non Executive Director |
| Mrs. Dhara Shah | Independent Director |
| Mr. Neeraj Golas | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Lyka Labs
What is the share price of Lyka Labs?
The share price of Lyka Labs on 13 Mar, 2025 is ₹ 99.35.
What is 52W high and 52W low share price of Lyka Labs?
The highest and lowest 52W share prices of Lyka Labs are ₹ 175.950 and ₹ 90.200
What is the market cap of Lyka Labs?
The market capitalization of Lyka Labs as of 13 Mar, 2025 is ₹ 354.51 Crores
What is the P/E ratio of Lyka Labs?
The current P/E ratio of Lyka Labs as of 13 Mar, 2025 is 43.95
What is the PB ratio of Lyka Labs?
The PB ratio of Lyka Labs as of 13 Mar, 2025 is 4.82
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)